Why the study?
Does 18F-FDG PET accurately characterize malignancy in patients with adrenocortical tumors compared to CT and iodocholesterol scintigraphy?
Does 18F-FDG PET accurately characterize malignancy in patients with adrenocortical tumors compared to CT and iodocholesterol scintigraphy?
18F-FDG PET may accurately differentiate malignant from benign adrenocortical lesions, though larger confirmatory studies are needed.
Answers are grounded in this paper and cite their sources.
May differentiate adrenocortical carcinoma from benign lesions on 18F-FDG PET; hypothesis-generating and requires larger prospective validation.
DESIGN: This study is a preliminary report on 18F-fluorodeoxyglucose (18F-FDG) uptake for the characterization of hypersecretory or non-hypersecretory adrenocortical masses in patients without known neoplastic disease, thereby minimizing the presence of adrenal metastases, and without phaeochromocytoma, in comparison with computed tomography (CT) scanning and with iodocholesterol scintigraphy. METHODS: Thirteen consecutive patients with an adrenal mass scheduled to have surgery, underwent hormonal exploration, a CT scan for tumour size measurement and an 18F-FDG positron emission tomography scan. Eleven of these patients also had unenhanced density measurement at CT scan and iodocholesterol scintigraphy. RESULTS: CT-scanned adrenal masses ranged in size from 2.2 to 10 cm; attenuation value was <10 Hounsfield units (HUs) in two cases and >10 HU in nine. All benign lesions demonstrated iodocholesterol uptake. In the case of malignant tumours, results were non-homogeneous: no uptake, uptake and non-informative scintigraphy. All patients with an adrenocortical carcinoma had positive adrenal 18F-FDG uptake (n=3), one had a liver metastasis with positive 18F-FDG uptake, one showed 18F-FDG uptake in an adrenal metastasis from an unknown primary kidney tumour. All patients with a benign adrenocortical lesion had negative 18F-FDG uptake (n=9). Patients' lesions were hypersecretory (n=5), or non-hypersecretory (n=8), regardless of the pathology. CONCLUSION: This short preliminary study indicates that 18F-FDG gave a correct classification of tissue characterization with accurate identification of malignant lesions, as well as the disease stage (metastasis or primary). These promising preliminary results on adrenocortical lesions, seldom studied with 18F-FDG, are to be confirmed in larger series.
No takes yet. Share an insight, caveat, or question.
Tenenbaum et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: